Registered number: 09368869 | ||||||||
FOR THE YEAR ENDED 31/01/2024 | ||||||||
Prepared By: | ||||||||
Berry Kearsley Stockwell Ltd | ||||||||
Accountants | ||||||||
Sterling House | ||||||||
31-32 High Street | ||||||||
Wellingborough | ||||||||
Northants | ||||||||
NN8 4HL |
Durja Pharma Limited | ||||||||
ACCOUNTS | ||||||||
FOR THE YEAR ENDED 31/01/2024 | ||||||||
DIRECTORS | ||||||||
REGISTERED OFFICE | ||||||||
Warwickshire | ||||||||
COMPANY DETAILS | ||||||||
Private company limited by shares registered in EW - England and Wales, registered number 09368869 | ||||||||
ACCOUNTANTS | ||||||||
Berry Kearsley Stockwell Ltd | ||||||||
Accountants | ||||||||
Sterling House | ||||||||
31-32 High Street | ||||||||
Wellingborough | ||||||||
Northants | ||||||||
NN8 4HL |
Durja Pharma Limited | ||||||||
ACCOUNTS | ||||||||
FOR THEYEARENDED31/01/2024 | ||||||||
CONTENTS | ||||||||
Page | ||||||||
Directors' Report | - | |||||||
Accountants' Report | - | |||||||
Statement Of Comprehensive Income | - | |||||||
Balance Sheet | 3 | |||||||
Notes To The Accounts | 4 | |||||||
The following do not form part of the statutory financial statements: | ||||||||
Trading And Profit And Loss Account | - | |||||||
Profit And Loss Account Summaries | - |
Durja Pharma Limited | ||||||||
BALANCE SHEET AT | ||||||||||
2024 | 2023 | |||||||||
Notes | £ | £ | ||||||||
FIXED ASSETS | ||||||||||
Tangible assets | 2 | |||||||||
CURRENT ASSETS | ||||||||||
Debtors | 3 | |||||||||
Cash at bank and in hand | ||||||||||
60,603 | 28,250 | |||||||||
CREDITORS: Amounts falling due within one year | 4 | |||||||||
NET CURRENT ASSETS | 13,515 | |||||||||
TOTAL ASSETS LESS CURRENT LIABILITIES | ||||||||||
PROVISIONS FOR LIABILITIES AND CHARGES | 6 | |||||||||
NET ASSETS | ||||||||||
CAPITAL AND RESERVES | ||||||||||
Called up share capital | 7 | |||||||||
Profit and loss account | 41,816 | 35,265 | ||||||||
SHAREHOLDERS' FUNDS | ||||||||||
Approved by the board on | ||||||||||
............................. | ||||||||||
Director | ||||||||||
Durja Pharma Limited | ||||||||
NOTES TO THE ACCOUNTS | ||||||||||
FOR THE YEAR ENDED 31/01/2024 | ||||||||||
1. ACCOUNTING POLICIES |
1a. Basis Of Accounting | ||||||||
The accounts have been prepared under the historical cost convention. | ||||||||
The accounts have been prepared in accordance with FRS102 - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 . |
1b. Depreciation | ||||||||
Motor Cars | reducing balance 25% |
1c. Pension Costs | ||||||||
The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year. |
2. TANGIBLE FIXED ASSETS | ||||||
Equipment | Motor Cars | Total | ||||
£ | £ | £ | ||||
Cost | ||||||
At 01/02/2023 | 1,330 | 38,685 | 40,015 | |||
At 31/01/2024 | 1,330 | 38,685 | 40,015 | |||
Depreciation | ||||||
At 01/02/2023 | 1,330 | 9,671 | 11,001 | |||
For the year | - | 7,254 | 7,254 | |||
At 31/01/2024 | 1,330 | 16,925 | 18,255 | |||
Net Book Amounts | ||||||
At 31/01/2024 | 21,760 | |||||
At 31/01/2023 | 29,014 | |||||
Durja Pharma Limited | ||||||||
3. DEBTORS | 2024 | 2023 | ||||||
£ | £ | |||||||
Amounts falling due within one year | ||||||||
Trade debtors | 21,132 | 14,287 | ||||||
Directors current account | - | 8,510 | ||||||
21,132 | 22,797 | |||||||
4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||||||||
2024 | 2023 | |||||||
£ | £ | |||||||
UK corporation tax | 25,018 | 8,914 | ||||||
VAT | 8,318 | 4,942 | ||||||
Directors current account | 215 | - | ||||||
Trade creditors | 1,128 | - | ||||||
Accruals | 919 | 879 | ||||||
35,598 | 14,735 | |||||||
5. EMPLOYEES | ||||||
2024 | 2023 | |||||
No. | No. | |||||
Average number of employees | 1 | |||||
6. PROVISIONS FOR LIABILITIES | 2024 | 2023 | ||||||
£ | £ | |||||||
Deferred taxation | 4,929 | 7,254 | ||||||
4,929 | 7,254 | |||||||
Durja Pharma Limited | ||||||||
7. SHARE CAPITAL | 2024 | 2023 | ||||||
£ | £ | |||||||
Allotted, issued and fully paid: | ||||||||
20 | 10 | |||||||
20 | 10 | |||||||
New shares issued during period: | ||||||||
10 | 10 | |||||||
10 | - | |||||||
8. RELATED PARTY TRANSACTIONS | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||